Chipscreen(688321)2024-10-30 10:54Financial Performance - Operating revenue for Q3 2024 was ¥178,954,534.61, an increase of 67.27% compared to the same period last year[2] - Net profit attributable to shareholders was -¥10,078,540.92, with a year-to-date loss of -¥51,084,939.83, representing a decrease of 147.26% year-on-year[2] - Basic and diluted earnings per share for the year-to-date period were both -¥0.1252, reflecting a decrease of 147.26% year-on-year[2] - The net profit for Q3 2024 was -51,084,939.83 RMB, compared to a profit of 68,432,323.32 RMB in Q3 2023, representing a significant decline[18] - The total comprehensive income for Q3 2024 was -51,588,378.16 RMB, down from 70,373,533.42 RMB in the same period last year[19] - Basic and diluted earnings per share for Q3 2024 were both -0.1252 RMB, compared to 0.2649 RMB in Q3 2023[19] Cash Flow - Cash flow from operating activities for Q3 2024 was ¥59,016,488.83, a significant increase of 530.08% compared to the same period last year[2] - Cash flow from operating activities for the first three quarters of 2024 was 74,564,294.54 RMB, a recovery from -112,013,154.32 RMB in the same period last year[22] - Cash inflow from investment activities in Q3 2024 was 1,106,464,509.65 RMB, compared to 750,839,196.43 RMB in Q3 2023[22] - Cash outflow from investment activities totaled 1,386,493,392.38 RMB in Q3 2024, compared to 1,135,517,773.31 RMB in Q3 2023[22] - Cash flow from financing activities in Q3 2024 was 132,141,925.49 RMB, down from 339,051,069.70 RMB in Q3 2023[22] Assets and Liabilities - Total assets at the end of Q3 2024 were ¥3,338,141,167.42, an increase of 4.21% from the end of the previous year[3] - The company's total assets increased to CNY 3,338,141,167.42, compared to CNY 3,203,249,429.12 at the end of the previous year, reflecting a growth of about 4.2%[15] - The total liabilities of the company rose to CNY 1,694,830,204.04 from CNY 1,493,353,557.17, which is an increase of about 13.5%[15] - The company's cash and cash equivalents decreased to CNY 134,282,130.33 from CNY 216,717,350.00, representing a decline of approximately 38.2%[14] - Inventory levels increased slightly to CNY 49,417,728.34 from CNY 47,129,293.63, showing a growth of about 4.8%[14] - The total equity attributable to shareholders decreased to CNY 1,643,310,963.38 from CNY 1,709,895,871.95, reflecting a decline of approximately 3.9%[16] - Short-term borrowings decreased significantly to CNY 71,161,547.64 from CNY 130,112,786.24, indicating a reduction of about 45.3%[15] Research and Development - R&D expenses totaled ¥65,497,591.41, a decrease of 11.08% year-on-year, representing 36.60% of operating revenue, down 32.25 percentage points[3] - Research and development expenses for the first three quarters of 2024 were CNY 147,574,384.70, down from CNY 211,230,689.78 in the previous year, indicating a decrease of approximately 30.2%[17] Shareholder Information - The total number of common shareholders at the end of the reporting period is 18,601[9] - The largest shareholder, BGI Group, holds 34,705,162 shares, representing 8.51% of total shares[9] - The second-largest shareholder, Shenzhen Haiyue Men Biotechnology Development Co., Ltd., holds 22,936,008 shares, representing 5.62%[9] - The company had a total of 15,285,290 shares held by Shenzhen Haide Kangcheng Investment Partnership, representing 3.75% of total shares[12] - The company had no outstanding shares borrowed for margin trading at the end of the reporting period[11] - The company has a consistent shareholder structure with several entities having a unified action relationship[10] - The company had no changes in the number of shares held by major shareholders due to margin trading activities[12] Financial Reporting - The company’s financial statements are unaudited for the reporting period[13] - The company’s total assets and liabilities will be detailed in the upcoming financial reports[13] - Shenzhen Micu Biotechnology Co., Ltd. will implement new accounting standards starting in 2024, affecting the financial statements from the beginning of the year[23] - The company reported its Q3 2024 financial results on October 31, 2024[23] - The board of directors announced the adjustments related to the first-time execution of the new accounting standards[23] - No specific performance metrics or user data were disclosed in the report[23] - Future outlook and performance guidance were not provided in the document[23] - There were no mentions of new product or technology developments in the report[23] - Market expansion and acquisition strategies were not discussed in the content[23] - Other new strategies were not highlighted in the financial report[23] - The document does not contain specific financial figures or percentages related to performance[23] - The report is classified as not applicable for the new accounting standards implementation[23]